comparemela.com

Page 3 - Shanej Schaffer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Baystreet ca - Cingulate Drops in Price on FDA Guidance

Cingulate Inc. (NASDAQ: CING) shares weakened, as the drug company announced that it has received guidance from the Food and Drug Administration (FDA) on advancing its investigational asset CTx-2103 (buspirone) for the treatment of anxiety into clinical .

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Cingulate to Host CNS Key Opinion Leader Panel in New York City

Cingulate to Host CNS Key Opinion Leader Panel in New York City
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.